In this study, the liver steatosis levels had no correlation with GGT, platelet count, and GPR, along with no correlation between steatosis and fibrosis, which might help explain why the GPR works in CHB-NAFLD patients. The gene discussed is ALDH18A1; the disease is metabolic dysfunction-associated steatotic liver disease.